Costs for heart failure with normal vs reduced ejection fraction

被引:100
作者
Liao, L
Jollis, JG
Anstrom, KJ
Whellan, DJ
Kitzman, DW
Aurigemma, GP
Mark, DB
Schulman, KA
Gottdiener, JS
机构
[1] Duke Univ, Ctr Med, Durham, NC 27710 USA
[2] Duke Clin Res Inst, Durham, NC 27710 USA
[3] Jefferson Heart Inst, Philadelphia, PA USA
[4] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[5] Univ Massachusetts, Med Ctr, Worcester, MA USA
[6] Univ Maryland, Sch Med, Baltimore, MD USA
关键词
D O I
10.1001/archinte.166.1.112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Among the elderly population, heart failure (HF) with normal ejection fraction (EF) is more common than classic HF with low EF. However, there are few data regarding the costs of HF with normal EF. In a prospective, population-based cohort of elderly participants, we compared the costs and resource use of patients with HF and normal and reduced EF. Methods: A total of 4549 participants (84.5% white; 40.6% male) in the National Heart, Lung, and Blood Institute Cardiovascular Health Study were linked to Medicare claims from 1992 through 1998. By protocol echo examinations or clinical EF assessments, 881 participants with HF were characterized,as having abnormal or normal EF. We applied semiparametric estimators to calculate mean costs per subject for a 5-year period. Results: There were 495 HF participants with normal EF (186 prevalent at study entry and 309 incident during the study period) and 386 participants with abnormal EF (166 prevalent and 220 incident). Participants with abnormal EF had more cardiology encounters and cardiac procedures. However, compared with abnormal EF participants, the 5-year costs for normal EF participants were similar in both the prevalent ($33 023 with abnormal EF and $32 580 with normal EF; P=.93) and incident ($49 128 with abnormal EF and $45 604 with normal EF; P=.55) groups. In models accounting for comorbid conditions, the costs with normal and abnormal EF remained similar. Conclusions: Over a 5-year period, patients with HF and normal EF consume as many health care resources as those with reduced EF. These data highlight the substantial financial burden of HF with normal EF among the elderly population.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 2001 HEART STROK STA
[2]   Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The Cardiovascular Health Study [J].
Aurigemma, GP ;
Gottdiener, JS ;
Shemanski, L ;
Gardin, J ;
Kitzman, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (04) :1042-1048
[3]   Estimating medical costs with censored data [J].
Bang, H ;
Tsiatis, AA .
BIOMETRIKA, 2000, 87 (02) :329-343
[4]   Economics of chronic heart failure [J].
Berry, C ;
Murdoch, DR ;
McMurray, JJV .
EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) :283-291
[5]   National trends in the initial hospitalization for heart failure [J].
Croft, JB ;
Giles, WH ;
Pollard, RA ;
Casper, ML ;
Anda, RF ;
Livengood, JR .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (03) :270-275
[6]   Heart failure associated with preserved systolic function: A common and costly clinical entity [J].
Dauterman, KW ;
Massie, BM ;
Gheorghiade, M .
AMERICAN HEART JOURNAL, 1998, 135 (06) :S310-S319
[7]   Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome [J].
Eisenstein, EL ;
Peterson, ED ;
Jollis, JG ;
Tardiff, BE ;
Califf, RM ;
Knight, JD ;
Mark, DB .
PHARMACOECONOMICS, 2000, 17 (03) :263-272
[8]  
Fried Linda P., 1991, Annals of Epidemiology, V1, P263
[9]  
GAASCH WH, 1994, JAMA-J AM MED ASSOC, V271, P1276
[10]  
Gold MR, 1996, COST EFFECTIVENESS H